FDA criticises government’s “absolutely illogical” decision on unconscious bias training

The FDA has branded the government’s decision to scrap unconscious bias training for civil servants as “absolutely illogical” and has criticised ministers for making the announcement without producing any proposals for what will replace it.
Speaking to the BBC’s Politics Live, FDA Assistant General Secretary Lucille Thirlby argued that the FDA has not been provided with any of the evidence on which the government says it has based the decision, despite being a recognised civil service trade union. Thirlby pointed out that there is significant evidence of bias leading to worse outcomes for those including BAME civil servants and civil servants with disabilities.
In comments picked up across media outlets, including by BBC News and the Guardian, Thirlby asked how the government is now going to ensure people are not discriminated against: “It’s easier to attack something than do something positive about it.”
Writing for Left Foot Forward, Thirlby called for ministers to get a better understanding of how workplaces operate rather than tinkering around the edges of diversity strategy. She made clear that the FDA and fellow trade unions “are always happy to talk to the government and debate the evidence, but the driver for change must not be an ideology that regards diversity as a gimmick that costs taxpayers’ money.”
She added that “if the government really wants inclusive and diverse workplaces and communities, they must come forward with the proposals to prove it.”
Related News
-
Lords Committee report highlights lack of evidence behind civil service 60% office working mandate
A new report from the House of Lords Select Committee on Home-Based Working, which features evidence from the FDA, says the government should lead by example with good hybrid working practices within the civil service.
-
2025 Wendy Jones Equality Award winner: Chloé François-Oatway
Katherine Hutchinson speaks to the winner of the Wendy Jones Equality Award 2025, Chloé François-Oatway.
-
FDA attends TUC LGBT Conference and London Pride
To mark the end of Pride Month, FDA delegations attended the TUC LGBT+ Conference and Pride in London.